Q1 results and buyback completion put Universal Health Services in focus

Universal Health Services (UHS) has drawn fresh attention after reporting first quarter 2026 sales of US$4,495.18 million, higher net income, and higher earnings per share compared with the prior year period.

Investor interest is also tied to the company’s latest update that it repurchased 675,000 shares for US$127.3 million in the first quarter, completing a long running buyback program first announced in 2014.

At a share price of US$170.56, Universal Health Services has a 1-day share price return of 1.23% and a 7-day share price return of 1.36%. However, the 30-day and year to date share price returns of 5.56% and 22.43% declines indicate that momentum has softened, even though the 3-year total shareholder return of 23.48% remains positive.

If this earnings driven move has you reassessing your watchlist, it can be useful to compare Universal Health Services with other healthcare focused opportunities using our screener for 35 healthcare AI stocks

With earnings, a completed buyback and a recent share price pullback, the key question now is whether Universal Health Services is trading below its underlying value or if the market is already pricing in future growth potential.

Most Popular Narrative: 24% Undervalued

According to the widely followed narrative by user yiannisz, Universal Health Services’ fair value of $224.48 sits well above the last close at $170.56, which puts the recent pullback into context for investors weighing fresh entry points or top ups.

Universal Health Services (NYSE: UHS) sits at the intersection of two powerful forces reshaping the U.S. healthcare system: rising demand for behavioral health services, and the increasing recognition that mental health infrastructure is essential, not optional. While much of the market focuses on technology-driven healthcare narratives, UHS continues to demonstrate that scale, clinical depth, and operational discipline remain decisive advantages in an environment defined by complexity and long-term demand.

Curious what drives a fair value so far above today’s share price? The narrative leans heavily on behavioral health strength, resilient margins, and assumed durability of cash generation. The real twist is how those cash flows are projected across both segments and then discounted.

Result: Fair Value of $224.48 (UNDERVALUED)

However, you still need to weigh risks such as a 22.43% year to date share price decline and flat net income growth alongside regulatory or reimbursement pressure on healthcare operators.

Next Steps

With mixed signals across earnings, valuation narratives and recent returns, it makes sense to review the full picture and move quickly to form your own view using the balance of 4 key rewards and 2 important warning signs

Looking for more investment ideas?

If you stop at just one stock, you risk missing other opportunities that might fit your goals even better, so broaden your search before making your next move.

• Spot potential bargains early by scanning screener containing 23 high quality undiscovered gems and see which under-the-radar stocks have fundamentals that could justify a closer look.
• Prioritize resilience by checking 71 resilient stocks with low risk scores to find companies with characteristics that may help steady your portfolio when conditions get choppy.
• Focus on financial strength by using the solid balance sheet and fundamentals stocks screener (44 results) to filter for businesses with balance sheets that might better support their long term plans.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.